HIMS partners with Novo Nordisk to offer FDA-approved GLP-1 medications
Go back to HIMS partners with Novo Nordisk to offer FDA-approved GLP-1 medications| (NYSE: HIMS) | Delayed: 33.54 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $33.54 | 52 Week High | $ | |||
| Open | $33.54 | 52 Week Low | $ | |||
| Day High | $33.54 | P/E | N/A | |||
| Day Low | $33.54 | EPS | $ | |||
| Volume | 407,183 | |||||
